mRNA vaccines — a new era in vaccinology

Cited by (1,011)

Items 1,001–1,011 of 1,011

  1. NIH funding for vaccine readiness before the COVID-19 pandemic
    Kiszewski, Anthony E., Cleary, Ekaterina Galkina, Jackson, Matthew J., Ledley, Fred D. · 2021 · Vaccine
  2. Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine
    LaTourette, Philip C., Awasthi, Sita, Desmond, Angela, Pardi, Norbert, Cohen, Gary H., Weissman, Drew, Friedman, Harvey M. · 2020 · Vaccine
  3. A Market Shaping Approach for the Biopharmaceutical Industry: Governing Innovation Towards the Public Interest
    Mazzucato, Mariana, Li, Henry Lishi · 2021 · Journal of Law, Medicine & Ethics
  4. mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition
    Röltgen, Katharina, Nielsen, Sandra C. A., Arunachalam, Prabhu S., Yang, Fan, Hoh, Ramona A., Wirz, Oliver F., Lee, Alexandra S., Gao, Fei, Mallajosyula, Vamsee, Li, Chunfeng et al. · 2021
  5. A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy
    Moore, Kristine A., Leighton, Tabitha, Ostrowsky, Julia T., Anderson, Cory J., Danila, Richard N., Ulrich, Angela K., Lackritz, Eve M., Mehr, Angela J., Baric, Ralph S., Baylor, Norman W. et al. · 2023 · Vaccine
  6. Safety and efficacy assessment of an mRNA rabies vaccine in dogs, rodents, and cynomolgus macaques
    Li, Jianglong, Yu, Pengcheng, Liu, Qi, Xu, Long, Chen, Yan, Li, Yan, Zhang, Fan, Zhu, Wuyang, Peng, Yucai · 2024 · npj Vaccines
  7. From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases
    Pandey, Manish, Ojha, Divya, Bansal, Sakshi, Rode, Ambadas B., Chawla, Geetanjali · 2021 · Molecular Aspects of Medicine
  8. Impact of Immunotherapy on CD4 T Cell Phenotypes and Function in Cancer
    Saillard, Margaux, Cenerenti, Mara, Romero, Pedro, Jandus, Camilla · 2021 · Vaccines
  9. Safe and effective aerosolization of in vitro transcribed mRNA to the respiratory tract epithelium of horses without a transfection agent
    Legere, Rebecca M., Cohen, Noah D., Poveda, Cristina, Bray, Jocelyne M., Barhoumi, Rola, Szule, Joseph A., de la Concha-Bermejillo, Andrés, Bordin, Angela I., Pollet, Jeroen · 2021 · Scientific Reports
  10. Efficacy and Safety of the CVnCoV SARS-CoV-2 mRNA Vaccine Candidate: Results from Herald, a Phase 2b/3, Randomised, Observer-Blinded, Placebo-Controlled Clinical Trial in Ten Countries in Europe and Latin America
    Kremsner, Peter G., Guerrero, Rodolfo Andrés Ahuad, Arana, Eunate, Aroca Martinez, Gustavo Jose, Bonten, Marc J.M., Chandler, Reynaldo, Corral, Gonzalo, De Block, Eddie Jan Louis, Ecker, Lucie, Gabor, Julian Justin et al. · 2021
  11. An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose
    Nag, Kakon, Chandra Baray, Juwel, Rahman Khan, Maksudur, Mahmud, Asif, Islam, Jikrul, Myti, Sanat, Ali, Rostum, Haq Sarker, Enamul, Kumar, Samir, Hossain Chowdhury, Mobarak et al. · 2021 · Vaccine